Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Pagitane: Full Drug Profile
Medically reviewed by Min Clinic Staff | Updated: January 2026
Pagitane - General Information
Pagitane is a drug used to reduce levels of acetylcholine to return a balance with dopamine in the treatment and management of Parkinson's disease.
Pharmacology of Pagitane
Pagitane is a central anticholenergic used in the treatment of the symptoms of Parkinson's disease. It is a drug used to reduce levels of acetylcholine. Acetylcholine is usually in balance with dopamine neurotransmitters, however lower levels of dopamine are present in the brain of patients suffering from Parkinson's disease. By lowering levels of acetylcholine, it is thought that this balance may be restored.
Additional information about Pagitane
- Pagitane Indication
For treatment and management of Parkinson's disease.
- Mechanism Of Action
- Pagitane binds the muscarinic acetylcholine receptor M1, effectively inhibiting acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of Parkinson's disease.
- Generic Name
- Cycrimine
- Synonyms
- Cycrimine hydrochloride
- Drug Category
- Antiparkinson Agents; Antidyskinetics
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Cycrimine
- Pagitane;
- Protein Binding
- 14-21%
- Chemical IUPAC Name
- 1-cyclopentyl-1-phenyl-3-piperidin-1-ylpropan-1-ol
- Chemical Formula
- C19H29NO
- Organisms Affected
- Humans and other mammals
